OmniAb (OABI) CEO reports RSU, option grants and tax sell-to-cover
Rhea-AI Filing Summary
OmniAb, Inc. President and CEO Matthew W. Foehr reported multiple equity transactions on February 18, 2026. He acquired 58,333 shares of common stock through the vesting and exercise of restricted stock units (RSUs) and received new awards of 156,250 RSUs and 1,562,500 stock options.
The vested RSUs represent a grant that vests in three substantially equal annual installments beginning on February 18, 2026, while the new RSU grant vests in three substantially equal annual installments beginning on February 18, 2027. The stock option grant becomes exercisable as to 12.5% of the underlying shares six months after the grant date, then in 42 substantially equal monthly installments.
To cover tax withholding obligations from the RSU vesting, 30,843 shares of common stock were sold at a weighted average price of $1.71 per share in transactions priced between $1.68 and $1.73. The filing states these are mandatory sell-to-cover transactions under the company’s equity incentive plans and not discretionary trades.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 58,333 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 156,250 | $0.00 | -- |
| Grant/Award | Stock Option | 1,562,500 | $0.00 | -- |
| Exercise | Common Stock | 58,333 | $0.00 | -- |
| Sale | Common Stock | 30,843 | $1.71 | $53K |
Footnotes (1)
- Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 18, 2026. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.73. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The RSU grant vests in three substantially equal annual installments beginning on February 18, 2027. The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.